2
|
Patel K, Rajendran A, Faiz O, Rutter MD, Rutter C, Jover R, Koutroubakis I, Januszewicz W, Ferlitsch M, Dekker E, MacIntosh D, Ng SC, Kitiyakara T, Pohl H, Thomas-Gibson S. An international survey of polypectomy training and assessment. Endosc Int Open 2017; 5:E190-E197. [PMID: 28299354 PMCID: PMC5348296 DOI: 10.1055/s-0042-119949] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/12/2023] Open
Abstract
Background and study aims Colonic polypectomy is acknowledged to be a technically challenging part of colonoscopy. Training in polypectomy is recognized to be often inconsistent. This study aimed to ascertain worldwide practice in polypectomy training. Patients and methods An electronic survey was distributed to endoscopic trainees and trainers in 19 countries asking about their experiences of receiving and delivering training. Participants were also asked about whether formal polypectomy training guidance existed in their country. Results Data were obtained from 610 colonoscopists. Of these responses, 348 (57.0 %) were from trainers and 262 (43.0 %) from trainees; 6.6 % of trainers assessed competency once per year or less often. Just over half (53.1 %) of trainees had ever had their polypectomy technique formally assessed by any trainer. Approximately half the trainees surveyed (51.1 %) stated that the principles of polypectomy had only ever been taught to them intermittently. Of those trainees with the most colonoscopy experience, who had performed over 500 procedures, 48.2 % had had training on removing large polyps of over 10 mm; 46.2 % (121 respondents) of trainees surveyed held no record of the polypectomies they had performed. Only four of the 19 countries surveyed had specific guidelines on polypectomy training. Conclusions A significant number of competent colonoscopists have never been taught how to perform polypectomy. Training guidelines worldwide generally give little direction as to how trainees should acquire polypectomy skills. The learning curve for polypectomy needs to be defined to provide reliable guidance on how to train colonoscopists in this skill.
Collapse
Affiliation(s)
- K. Patel
- Wolfson Unit for Endoscopy, St Mark’s Hospital, London, UK,Imperial College, London, UK,Corresponding author Kinesh Patel St Mark’s Hospital – Wolfson Unit for EndoscopyWatford RoadLondon HA1 3UJUK+44-20-30041010
| | - A. Rajendran
- Wolfson Unit for Endoscopy, St Mark’s Hospital, London, UK,King’s College London, London, UK
| | - O. Faiz
- Wolfson Unit for Endoscopy, St Mark’s Hospital, London, UK,Imperial College, London, UK
| | - M. D. Rutter
- North Tees & Hartlepool NHS Foundation Trust, Stockton-on-Tees, UK,Durham University, Durham, Co. Durham, UK
| | - C. Rutter
- British Society of Gastroenterology, UK
| | - R. Jover
- Hospital General Universitario de Alicante, Alicante, Spain
| | | | - W. Januszewicz
- The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland,Department of Gastroenterology and Hepatology, Medical Center for Postgraduate Education, Warsaw, Poland
| | | | - E. Dekker
- Academic Medical Center, Amsterdam, Netherlands
| | - D. MacIntosh
- Dalhousie University, Halifax, Nova Scotia, Canada
| | - S. C. Ng
- Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, China
| | - T. Kitiyakara
- Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
| | - H. Pohl
- Geisel School of Medicine, Dartmouth, Hanover, NH, USA
| | - S. Thomas-Gibson
- Wolfson Unit for Endoscopy, St Mark’s Hospital, London, UK,Imperial College, London, UK
| |
Collapse
|
3
|
Abstract
Primary sclerosing cholangitis (PSC) is a chronic inflammatory disease that causes fibrosis of the biliary tree. Life expectancy of patients is reduced by liver failure and a high incidence of malignancy. It is closely associated with inflammatory bowel disease, particularly ulcerative colitis, which coexists in approximately three-quarters of northern European patients. Cancers include cholangiocarcinoma, gallbladder cancer, hepatocellular carcinoma, pancreatic cancer and colorectal cancer. Ursodeoxycholic acid appears to reduce the incidence of colorectal neoplasia in patients with PSC, and there is some suggestion that it may also reduce the incidence of cholangiocarcinoma. A chemoprotective benefit of 5-aminosalicylates has not been confirmed in patients with PSC with associated inflammatory bowel disease. There is no accepted screening programme for cholangiocarcinoma, but methods for detecting early disease using biochemical markers, scanning using positron emission tomography or MRI, and endoscopic procedures such as endosonography and endoscopic retrograde cholangiopancreatography are discussed. A combination of techniques is often used in an attempt to diagnose early cholangiocarcinoma. Cholecystectomy should be performed for gallbladder polyps, as many are malignant, and ultrasonography and alpha-fetoprotein testing are suggested for screening for hepatocellular carcinoma. Colorectal carcinoma screening should be performed after the diagnosis of PSC, and surveillance colonoscopy should be performed annually if there is concomitant colitis.
Collapse
Affiliation(s)
- T Kitiyakara
- Department of Gastroenterology and Hepatology, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK
| | | |
Collapse
|
5
|
Abstract
BACKGROUND Uncertainty exists as to whether dysplastic polyps in ulcerative colitis should always be managed as dysplasia-associated lesions/masses requiring colectomy, or whether some can be managed by polypectomy. The prevalence of non-inflammatory polyps in ulcerative colitis is unknown. AIM To compare dysplastic polyp occurrence in patients with ulcerative colitis and in patients without inflammatory bowel disease. METHODS The clinical, endoscopic and histological records of 150 ulcerative colitis patients (median disease duration, 10 years; 57% with pancolitis) undergoing colonoscopy were scrutinized for any polyp history. Two hundred and five patients undergoing colonoscopy for altered bowel habit, but without features suggestive of polyp presence, were used as a control group. Immunohistochemical staining of flat and polypoid mucosa for p16, beta-catenin, p53 and cyclo-oxygenase-2 was compared in the two groups. RESULTS Only six (4%) ulcerative colitis patients had ever had dysplastic polyps. Two had single adenomatous polyps proximal to the colitis segment. Of the four patients with dysplastic polyps within colitic mucosa, two were treated endoscopically, but in two the lesions were considered to be dysplasia-associated lesions/masses and colectomy was advised. In contrast, 24 controls had at least one adenomatous polyp (chi(2) = 6.7, P < 0.01). Ten (6.7%) ulcerative colitis patients and 24 (12%) control patients had metaplastic polyps (N.S.). Immunohistochemical staining was not discriminatory. CONCLUSION Despite the increased cancer risk in long-standing ulcerative colitis, adenomatous polyps arise less frequently in ulcerative colitis patients than in patients without ulcerative colitis.
Collapse
Affiliation(s)
- T Kitiyakara
- Department of Gastroenterology, Wycombe Hospital, High Wycombe, Buckinghamshire, UK
| | | | | | | |
Collapse
|